FACTORS AFFECTING INTERMEDIATE-DOSE METHOTREXATE (MTX) CLEARANCE (CL) IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)

被引：0
|
作者：
CROM, WR [1 ]
GLYNN, AM [1 ]
EVANS, WE [1 ]
机构：
[1] ST JUDE CHILDRENS RES HOSP,DIV PHARMACEUT,PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [21] MODERATE DOSE METHOTREXATE, VINCRISTINE, ASPARAGINASE, AND DEXAMETHASONE FOR TREATMENT OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA
    ESTERHAY, RJ
    WIERNIK, PH
    GROVE, WR
    MARKUS, SD
    WESLEY, MN
    BLOOD, 1982, 59 (02) : 334 - 345
  • [22] IMMUNOLOGICAL FACTORS IN THE PROGNOSIS OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    LEIKIN, S
    MILLER, D
    SATHER, H
    ALBO, V
    VITALE, L
    ROGENTINE, N
    HAMMOND, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 372 - 372
  • [23] INFLUENCE OF SERUM CONCENTRATION ON RENAL CLEARANCE OF METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    STEWART, CF
    CROM, WR
    BOWMAN, WP
    HUTSON, PR
    EVANS, WE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (06): : 482 - 482
  • [24] HIGH DOSE METHOTREXATE (HDM) IN ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
    FREEMAN, A
    WANG, J
    SINKS, L
    BLOOD, 1975, 46 (06) : 1040 - 1040
  • [25] THE ACUTE HEPATOTOXICITY OF INTERMEDIATE-DOSE MTX IN CHILDREN WITH ACUTE-LEUKEMIA AND NON-HODGKIN-LYMPHOMA
    EXADAKTYLOS, P
    REISS, T
    SCHOBESS, R
    HOMMANN, M
    HOHNE, S
    BECK, A
    KLINISCHE PADIATRIE, 1994, 206 (04): : 315 - 318
  • [26] THERAPY OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD WITH INTERMEDIATE DOSE METHOTREXATE AND CNS IRRADIATION - A REPORT OF THE ALL 77-02 STUDY-GROUP
    HAAS, RJ
    JANKA, G
    GAEDICKE, G
    KOHNE, E
    NETZEL, B
    BLUT, 1983, 47 (06): : 321 - 331
  • [27] INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    CAMITTA, B
    LEVENTHAL, B
    LAUER, S
    SHUSTER, JJ
    ADAIR, S
    CASPER, J
    CIVIN, C
    GRAHAM, M
    MAHONEY, D
    MUNOZ, L
    KIEFER, G
    KAMEN, B
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) : 1539 - 1544
  • [28] DEVELOPMENTAL OUTCOMES FOLLOWING TREATMENT FOR ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    TAYLOR, HG
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 13 (03) : 287 - 287
  • [29] ESTABLISHMENT OF METHOTREXATE (MTX)-RESISTANT HUMAN ACUTE LYMPHOCYTIC-LEUKEMIA CELLS IN CULTURE AND EFFECTS OF VARIOUS ANTIFOLS
    OHNOSHI, T
    OHNUMA, T
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 298 - 298
  • [30] CONTINUOUS INFUSION (CI) METHOTREXATE (MTX) AND TENIPOSIDE (T) FOR PEDIATRIC ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - SYSTEMIC PHARMACOKINETICS AND DOSAGE REGIMEN ADJUSTMENT
    RODMAN, JH
    SUNDERLAND, M
    KAVANAGH, R
    OCHS, J
    YALOWICH, JC
    EVANS, WE
    PHARMACOTHERAPY, 1988, 8 (02): : 137 - 137
12345